Dr. Simon K. Lo, MD

Dr. Lo practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Lo's NPI, 1255368874, was assigned on June 27, 2006. Dr. Lo graduated from New York University School of Medicine in 1982. Dr. Lo's California license number on file is G51850.

Dr. Lo's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Lo's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lo practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lo's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lo is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Lo has a license on file in California.

Dmand AI lists acid reflux, bile duct problems, colonoscopy, esophagus, stomach, or upper small intestine surgery, intestinal or bowel obstruction, irritable bowel syndrome (IBS), pancreas or bile duct endoscopy (ERCP) and pancreatitis among the conditions Dr. Lo treats.

CMS data shows 518 Medicare services from Dr. Lo across 15 procedure codes in 2024, for 349 Medicare patients. Medicare paid $77,495 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 349 Medicare patients who saw Dr. Lo in 2024. The largest group is 75 to 84, with 146 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lo's median patient age at 73, with 53% women.

In 2024, Dr. Lo wrote 65 Medicare Part D claims for 45 patients. 85% of them were for generic drugs. CMS names the drug for 19 of them, across 1 drug with 11 or more claims each, at $72 in total drug cost. In 2023, CMS named 30 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Lo for performance year 2024, reported as part of a group. Dr. Lo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lo as offering telehealth. CMS counts 274 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Lo, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 41 papers to Dr. Lo, published from 2006 to 2025. 2019 was the busiest year, with 8. The most frequent topics are Endoscopy, Gastrointestinal, Asian People and Developmental Disabilities. Dr. Lo has published most often in Endoscopy. Dr. Lo's most frequent co-authors are Laith Hikmet Jamil, MD, Srinivas Gaddam, MD and Nicholas N. Nissen, MD.

Dmand AI links Dr. Lo to 5 clinical trials. Conditions studied include Gastroesophageal Reflux, Esophageal Motility Disorders and Pancreatic Neoplasms. Cedars-Sinai Medical Center sponsors the most, 2.

CMS Open Payments shows 144 general payments to Dr. Lo from 13 drug and device companies from 2016 to 2025. Education make up the largest share, 62% of the total. Olympus Corporation of the Americas paid the most, $83,622.

Dmand AI lists 5 awards for Dr. Lo, most recently CMS Stage 1 EHR in 2013.

Dr. Lo graduated from New York University School of Medicine in 1982. Dr. Lo is a member of ACG.

Dr. Lo is in network with 5 carriers, including Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.